RecallDepth
Class II Terminated

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
February 1, 2019
Posted
February 13, 2019
Recall Number
D-0424-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10,390 bottles
Firm Location
Morgantown, WV, United States

Reason for Recall

Defective Container: Potential for broken glass in the neck area of the glass bottles.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot: GA70535, Exp. April 2019

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls